Abstract
An endogenous ligand for the GH secretagogue-receptor (GHS-R) has been recently purified from rat and human stomach and named Ghrelin. It has been demonstrated that Ghrelin specifically stimulates GH secretion from rat pituitary cells in culture as well as in rats in vivo. In this preliminary study, in 4 normal adults [age (mean±SE): 28.6±3.5 yr; body mass index (BMI): 22.3±2.1 kg/m2] we administered 1.0 μg/kg Ghrelin or GHRH-29 to compare their GH-releasing activities in humans. In all subjects Ghrelin induced a prompt, marked and long-lasting increase in circulating GH levels (peak: 107.9±26.1 μg/l; AUC: 6503.1±1632.7 μg/l/h). The GH response to Ghrelin was clearly higher (p<0.05) than that after GHRH (peak: 22.3±4.5 μg/l; AUC: 1517.5±338.4 μg/l/h). In conclusion, this preliminary study shows that Ghrelin exerts a strong stimulatory effect on GH secretion in humans releasing more GH than GHRH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Smith R.G., Van der Ploeg L.X.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18: 621–645.
Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol. 1997, 136: 445–460.
Deghenghi R. Synthetic peptides and their non-peptidyl mimetics in endocrinology: from synthesis to clinical perspectives. J. Endocrinol. Invest. 1998, 21: 787–793.
Arvat E., Broglio F., Giordano R., Muccioli G., Maccario M., Camanni F., Ghigo E. Hormonal activities of growth hormone secretagogues (GHS) across human lifespan. In: Ghigo E., Boghen M., Casanueva F.F., Dieguez C. (Eds.), Growth hormone secretagogues. Elsevier Science, Amsterdam, 1999, p. 139.
Muccioli G., Broglio F., Valetto M., Ghè C., Catapano F., Graziani A., Papotti M., Bisi G., Deghenghi R., Ghigo E. Growth hormone-releasing peptides and the cardiovascular system. Ann. Endocrinol. (Paris) 2000, 61: 27–31.
Kojima M., Hosoda H., Data Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999, 402: 656–660.
Kangawa K., Kojima M., Matsuo H. Isolation and implication of novel cardiovascular hormones. 82nd Annual Meeting of the Endocrine Society, Toronto, June 2000, abs. 172.
Dieguez C., Casanueva F.F. Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation. Eur. J. Endocrinol. 2000, 142: 413–417.
Gelato M.C., Pescovitz D.H., Cassorla F., Loriaux D.L., Merriam G.R. Dose-response relationships for the effects of GH-releasing factor 1-44NH2 in young adult men and women. J. Clin. Endocrinol. Metab. 1984, 59: 197–203.
Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J. Clin. Endocrinol. Metab. 1984, 78: 693–698.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arvat, E., Di Vito, L., Broglio, F. et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23, 493–495 (2000). https://doi.org/10.1007/BF03343763
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343763